Second AstraZeneca trial participant develops rare neurological condition following COVID-19 vaccination
by: Ethan Huff (Natural News) It has come to our attention that a second participant in AstraZeneca’s Wuhan coronavirus (COVID-19) vaccine trials has come down with a serious neurological condition that the company claims